Literature DB >> 9196889

Cytogenetic, morphologic and oncogene analysis of a cell line derived from a heterologous mixed mullerian tumor of the ovary.

J L Becker1, P R Papenhausen, R H Widen.   

Abstract

A cell line was established from a mixed mullerian tumor of the ovary and designated LN1. Histopathologic analysis of the fresh tumor specimen demonstrated a highly aneuploid heterologous tumor comprised of undifferentiated mesodermal components with carcinomatous cells present as a smaller population. Long-term in vitro culture resulted in the establishment of a cell line that exhibits an epithelial-like morphology and expresses epithelial antigens cytokeratin, epithelial membrane antigen, and carcinoma antigen TAG-72. These cells also express mesenchymal intermediate filaments, vimentin, and desmin. Karyotypic analysis revealed a basic triploid pattern with multiple chromosomal abnormalities, most notably an isochromosome of the short arm of five present in three copies. Analysis of oncogene expression revealed that LN1 cells constitutively express mRNA for c-ras, c-erbB2, and p53. The expression of mRNA for cellular oncogenes correlated with the presence of corresponding oncoproteins, p21H-ras, p21K-ras, and p185erB2 and mutant p53 protein. In summary, coexpression of epithelial and mesenchymal antigens by LN1 cells lends support to the hypothesis that epithelial and mesenchymal elements comprising mixed mullerian tumors of the ovary are derived from a common stem cell precursor. Furthermore, this cell line represents a functional in vitro model to evaluate the biologic activities of these unusual and highly aggressive ovarian malignancies.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9196889     DOI: 10.1007/s11626-997-0001-x

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  36 in total

1.  Characteristics of cell lines established from a mixed mesodermal tumor of the human ovary. Carcinomatous cells are changeable to sarcomatous cells.

Authors:  A Masuda; A Takeda; H Fukami; C Yamada; M Matsuyama
Journal:  Cancer       Date:  1987-12-01       Impact factor: 6.860

2.  Two homologous mixed müllerian tumor lines of the ovary and their characteristics.

Authors:  C van Haaften-Day; P Russell; S Brammah-Carr
Journal:  Cancer       Date:  1990-04-15       Impact factor: 6.860

3.  Cytogenetic studies in ovarian cancer.

Authors:  J Whang-Peng; T Knutsen; E C Douglass; E Chu; R F Ozols; W M Hogan; R C Young
Journal:  Cancer Genet Cytogenet       Date:  1984-01

4.  The relation between mixed mesodermal tumors and adenocarcinomas of the ovary. An immunopathologic study.

Authors:  L A Noorduyn; C J Herman
Journal:  Eur J Cancer Clin Oncol       Date:  1987-02

5.  Marker chromosomes of the long arm of chromosome 1 in endometrial carcinoma.

Authors:  H Fujita; N Wake; T Kutsuzawa; K Ichinoe; M M Hreshchyshyn; A A Sandberg
Journal:  Cancer Genet Cytogenet       Date:  1985-12

6.  Expression of ras oncogene p21 protein in normal and neoplastic ovarian tissues: correlation with histopathologic features and receptors for estrogen, progesterone, and epidermal growth factor.

Authors:  G Scambia; L Catozzi; P B Panici; G Ferrandina; F Coronetta; R Barozzi; G Baiocchi; L Uccelli; A Piffanelli; S Mancuso
Journal:  Am J Obstet Gynecol       Date:  1993-01       Impact factor: 8.661

7.  Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer.

Authors:  A Berchuck; A Kamel; R Whitaker; B Kerns; G Olt; R Kinney; J T Soper; R Dodge; D L Clarke-Pearson; P Marks
Journal:  Cancer Res       Date:  1990-07-01       Impact factor: 12.701

8.  p53 gene mutations and protein accumulation in human ovarian cancer.

Authors:  J Kupryjańczyk; A D Thor; R Beauchamp; V Merritt; S M Edgerton; D A Bell; D W Yandell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

9.  Marker profile of mesothelial cells versus ovarian carcinoma cells.

Authors:  C C van Niekerk; P H Jap; C M Thomas; D F Smeets; F C Ramaekers; L G Poels
Journal:  Int J Cancer       Date:  1989-06-15       Impact factor: 7.396

10.  Oncogene expression in vivo by ovarian adenocarcinomas and mixed-mullerian tumors.

Authors:  B M Kacinski; D Carter; E I Kohorn; K Mittal; R S Bloodgood; J Donahue; C A Kramer; D Fischer; R Edwards; S K Chambers
Journal:  Yale J Biol Med       Date:  1989 Jul-Aug
View more
  5 in total

Review 1.  Three-dimensional cultures of prostatic cells: tissue models for the development of novel anti-cancer therapies.

Authors:  K C O'Connor
Journal:  Pharm Res       Date:  1999-04       Impact factor: 4.200

2.  Three-dimensional culture of a mixed mullerian tumor of the ovary: expression of in vivo characteristics.

Authors:  T J Goodwin; T L Prewett; G F Spaulding; J L Becker
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-05       Impact factor: 2.416

Review 3.  Using space-based investigations to inform cancer research on Earth.

Authors:  Jeanne L Becker; Glauco R Souza
Journal:  Nat Rev Cancer       Date:  2013-04-12       Impact factor: 60.716

4.  Permanent phenotypic and genotypic changes of prostate cancer cells cultured in a three-dimensional rotating-wall vessel.

Authors:  H W Rhee; H E Zhau; S Pathak; A S Multani; S Pennanen; T Visakorpi; L W Chung
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-03       Impact factor: 2.723

5.  Temperature-sensitive ovarian carcinoma cell line (OvBH-1).

Authors:  Julia K Bar; Antonina Harlozinska; Sabine Kartarius; Mathias Montenarh; Ewa Wyrodek; Jan M Rodriguez Parkitna; Marian Kochman; Andrzej Ozyhar
Journal:  Jpn J Cancer Res       Date:  2002-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.